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METHODS: Maternally reported congenital abnormalities (CAs) were examined in a case–control study of 278 cases of paediatric germ
cell tumours (GCTs) and 423 controls.
RESULTS AND CONCLUSIONS: Germ cell tumours were significantly associated with cryptorchidism in males (OR¼10.8, 95% CI: 2.1–
55.1), but not with any other specific CA in either sex.
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The risk factors for paediatric germ cell tumours (GCTs), which
comprise a histologically heterogeneous group of tumours
affecting an estimated 360 individuals o15 years of age each year
in the United States (Bernstein et al, 1999; US Census Bureau,
2007), have not been well described (Bernstein et al, 1999).
However, congenital abnormalities (CAs) have often been reported
in association with GCTs in case series and in record linkage
studies (Li and Fraumeni, 1972; Fraumeni et al, 1973; Li et al, 1973;
Birch et al, 1982; Mann et al, 1993; Altmann et al, 1998; Little, 1999;
Nishi et al, 2000; Merks et al, 2005; Bjorge et al, 2008; Rankin et al,
2008). The presence of cryptorchidism is a confirmed risk factor
for testicular GCTs in men (Sarma et al, 2006), but its association
with paediatric GCTs has not been as well studied. We evaluated
the association between certain CAs and childhood GCTs by sex,
age at diagnosis, anatomical location, and histology in a Children’s
Oncology Group (COG) study.
MATERIALS AND METHODS
The study protocol was approved by the Institutional Review
Boards of the University of Minnesota and by the participating
COG institutions. Details regarding this study have been described
previously (Chen et al, 2005). Briefly, GCT cases with malignant
extracranial tumours, diagnosed from the time of birth to 14 years
of age between 1 January 1993 and 31 December 2001, were
ascertained from US and Canadian COG hospitals. Eligible
diagnoses were dysgerminoma–seminoma–germinoma, embryonal
carcinoma, yolk sac tumour, choriocarcinoma, malignant
teratoma, and mixed GCTs. Controls were recruited through
random digit dialling, and frequency was matched to cases on sex
and birth year±1 year, at ratios of approximately 1:2 for males
and 1:1 for females. Cases and controls were eligible if they had a
telephone in their residence and if their biological mother spoke
English and consented to an interview. Participation rates were 81
and 67% for cases and controls, respectively. Exposure informa-
tion was collected from mothers by telephone interview, including
the seven CA categories shown in Table 3.
Statistical analyses
We used SAS version 9.1. (SAS Institute Inc., Cary, NC, USA) to
conduct statistical analyses. Statistical differences in the frequency
or means of sociodemographic and infant characteristics between
cases and controls were assessed using Mantel–Haenszel w
2 tests
and one-way analysis of variance. We used unconditional logistic
regression to examine the associations between CAs and GCTs,
adjusting for the matching factors, sex and child’s age. We
conducted analyses stratified by sex, age at diagnosis (p2, 42
years), tumour histology, and anatomical location. As the number
of cases was small, the effect of potential confounding variables on
risk estimates was examined by adding them one at a time to
models. All statistical tests were two-sided.
RESULTS
In both sexes, GCTs occurred most frequently in the gonads, with
yolk sac tumours being the most common histological subtype,
followed by other non-seminomas in males and teratomas in
females. The distribution of age at diagnosis was bimodal, with
peaks observed before the age of 5 years and after the age of 10
years in both sexes (Table 1).
No statistical differences were found between cases and controls
with respect to gestational age, birth weight, or maternal age.
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white race than were case mothers. A higher frequency of cases had
household incomes below $20000 than did controls (Table 2).
In males, there were statistically significant increased risks of
GCTs in association with any CA (OR¼2.5, 95% CI: 1.3–4.9),
which was mainly because of cryptorchidism (OR¼10.8, 95% CI:
2.1–55.1). The risk of GCTs increased significantly with increasing
number of CAs in males (P for trend¼0.01). There were no other
significant associations between GCTs and CAs in either sex
(Table 3). Models that included the variables shown in Table 2 did
not materially change the results (data not shown).
There were no significant associations between CAs and GCTs in
children p2o r42 years, except for cryptorchidism, in which
risks were similar (ORp2 years¼8.2, 95% CI: 0.9–72.7; OR42
years¼14.6, 95% CI: 1.4–152.2) (data not shown).
Individuals with any CA had a significantly increased risk for
extragonadal GCTs (OR¼1.7, 95% CI: 1.0–2.9), with a signifi-
cantly positive linear trend with increasing number of CAs
(P¼0.009) (Supplementary Table 1). Statistically significant
increased risks were observed for GCTs in association with
cryptorchidism for gonadal (OR¼19.9, 95% CI: 3.5–111.9) but
not for extragonadal (OR¼3.0, 95% CI: 0.3–34.7) GCTs. For
extragonadal GCTs, significant increased risks were found in
association with mental retardation (OR¼15.8, 95% CI: 1.4–
178.0), congenital heart defects (OR¼2.7, 95% CI: 1.1–6.0), and
skeletal defects (OR¼5.0, 95% CI: 1.3–19.1). No significant
associations were observed between GCTs and CAs in analyses
stratified by histological subtype (seminoma, yolk sac tumour,
teratoma, and other non-seminomas), with the exception of
cryptorchidism, which increased the risk for seminomas
(OR¼57.0, 95% CI: 1.9–N), yolk sac tumours (OR¼11.1, 95%
CI: 1.6–75.6), and other non-seminomas (OR¼14.8, 95% CI: 1.5–
147.4). Cryptorchidism was not reported in any males with
teratomas (n¼14) (data not shown).
DISCUSSION
In the largest case–control study of paediatric GCTs, we
found limited evidence for an overall association between
paediatric GCTs and Cas, with the exception of cryptorchidism.
Other controlled studies have reported positive associations
between paediatric GCTs and CAs, including any birth defect
(Mann et al, 1993; Altmann et al, 1998; Bjorge et al, 2008),
heart defects (Nishi et al, 2000), cryptorchidism (Nishi et al, 2000),
and musculoskeletal/spinal abnormalities (Narod et al, 1997;
Agha et al, 2005).
In males, there was an B11-fold increased risk of GCTs in
association with cryptorchidism, which is consistent with findings
from adult testicular cancer studies (Sarma et al, 2006).
Cryptorchidism in children with GCTs has been noted previously
in case series and reports (Li and Fraumeni, 1972; Huddart et al,
1990; Mukai et al, 1998) and in isolated cases in studies with
comparison groups (Johnston et al, 1986; Wanderas et al, 1998).
The excess risk in this study was primarily confined to gonadal
tumours, with increased risks evident for seminomas, yolk-sac
tumours, and other non-seminomas, which is consistent with what
has been reported for adults (Coupland et al, 1999).
In females, there was no evidence of an association between CAs
and GCTs. Reports of congenital ovarian abnormalities in
association with ovarian GCTs are uncommon, with one case
series study noting two cases of ovarian dysgenesis (Li et al, 1973);
no such case was recorded in our study.
We observed an increased risk of extragonadal GCTs in
individuals with reported skeletal defects, mental retardation,
and congenital heart defects. Associations between skeletal and
congenital heart defects and GCTs have been reported previously,
but have not specified the tumour site (Narod et al, 1997; Nishi
et al, 2000; Agha et al, 2005).
The strengths of this study include its relatively large size
compared with that of previous studies and a more detailed
analysis of previously reported associations. Limitations include
CA ascertainment through a maternal interview that may be
Table 1 Characteristics of paediatric GCT diagnoses
Tumour characteristics
No. of males
(%)
No. of females
(%)
Anatomical location
Testis/ovary 47 (56.6) 97 (49.7)
Extragonadal 31 (37.4) 89 (45.6)
Metastatic 3 (3.6) 4 (2.1)
Unknown 2 (2.4) 5 (2.6)
Histology
Yolk sac tumour 46 (55.4) 79 (40.5)
Teratoma 14 (16.9) 57 (29.2)
Seminoma 2 (2.4) 43 (22.1)
Other non-seminomas
a 17 (20.5) 8 (4.1)
Other
b 3 (3.6) 7 (3.6)
Not specified 1 (1.2) 1 (0.51)
Diagnosis age category (years)
0–4 64 (77.1) 84 (43.1)
5–9 4 (4.8) 37 (19.0)
10–14 15 (18.1) 74 (38.0)
Total 83 (100.0) 195 (100.0)
GCT¼germ cell tumour.
aEmbryonal carcinoma, choriocarcinoma, polyembryoma.
bMixed germ cell tumour components and malignant tumour cells.
Table 2 Infant and parental sociodemographic characteristics of cases
and controls
Characteristics
No. of
cases (%)
No. of
controls (%) P-value
Gestational age category (weeks)
o37 35 (12.6) 44 (10.4)
37–42 236 (84.9) 367 (86.8)
442 7 (2.5) 12 (2.8) 0.37
Mean (s.d.) 39.5 (5.6) 39.6 (4.6) 0.76
Birth weight (grams)
2501–4000 214 (77.0) 351 (83.0)
p2500 22 (7.9) 26 (6.1)
44000 42 (15.1) 46 (10.9) 0.05
Mean (s.d.) 3354 (681) 3373.7 (590) 0.69
Maternal age category (years)
p24 90 (32.4) 128 (30.3)
25–29 99 (35.6) 145 (34.3)
30–34 60 (21.6) 111 (26.2)
X35 29 (10.4) 39 (9.2) 0.56
Mean (s.d.) 27.2 (5.5) 27.3 (5.4) 0.66
Maternal education
Less than high school 28 (10.1) 23 (5.4)
High school graduate 110 (39.7) 143 (33.9)
College, no degree 53 (19.1) 97 (23.0)
College degree and/or
graduate school
86 (31.1) 159 (37.7) 0.004
Maternal race
White 213 (76.9) 356 (84.4)
Black 25 (9.0) 25 (5.9)
Hispanic 27 (9.8) 23 (5.4)
Other 12 (4.3) 18 (4.3) 0.05
Household income (US dollars)
o20000 85 (31.0) 83 (19.9)
20000–30000 60 (21.9) 109 (26.1)
30001–50000 63 (23.0) 124 (29.7)
450000 66 (24.1) 102 (24.4) 0.03
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The ascertainment of CAs may have been higher in cases because
of the cancer investigations, which would produce a positive bias
in the risk estimate (Rothman and Greenland, 1998). We were also
limited by low statistical power to detect modest associations.
Finally, selection bias may have affected our results if controls
were not a representative of a sample of non-diseased individuals
from the population from which cases were ascertained (Rothman
and Greenland, 1998).
This study provides limited evidence for a link between most
types of CAs and paediatric GCTs with the exception of
cryptorchidism in males, and a possible link between certain
types of CAs and extragonadal tumours.
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